A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer (Q34363435)
scientific article
Language:
(P31) (Q13442814)
(P304) 1637-1643
(P407) (Q1860)
(P433) 11
(P478) 103
(P577) Tuesday, November 2, 2010
(P921) (Q32089)
(P1433) (Q326309)
(P1476) "A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer" (language: en)
(P2093) I M E Desar
J N H Timmer-Bonte
D M Burger
W T A van der Graaf
C M L van Herpen
(P2860) (Q33658626)
(Q34088265)
(Q27851481)
(Q37463883)
(Q37227994)
(Q24658334)
(Q37283073)
(Q33383268)
(Q33380559)
(Q37022440)
(Q36838789)
(Q28282767)
(Q36650719)
(Q33370229)
(Q33369361)
(Q34556363)
(Q33925690)
(Q27860904)
(Q24316075)
(Q46728461)
other details